transform
organ
transplant
interest
experi
human
immunobiolog
practic
mean
rehabilit
patient
varieti
form
end
organ
dysfunct
may
outstand
clinic
accomplish
biomed
revolut
occur
last
three
decad
inde
rate
one
year
graft
surviv
mani
center
nonpulmonari
allograft
approach
even
exce
compar
statist
lung
allograft
despit
success
transplant
patient
evid
microbi
invas
first
year
consequ
invas
quit
divers
encompass
follow
direct
consequ
microbi
invas
result
varieti
clinic
infecti
diseas
syndrom
mononucleosi
pneumonia
gastroenter
hepat
etc
indirect
consequ
cytokin
chemokin
growth
factor
elabor
transplant
recipi
respons
microbi
replic
invas
contribut
net
state
immunosuppress
pathogenesi
acut
chronic
allograft
injuri
even
case
develop
malign
given
array
clinic
effect
infect
transplant
patient
prevent
rather
treatment
establish
clinic
diseas
becom
primari
goal
practition
transplant
infecti
diseas
goal
mind
guidelin
prepar
analysi
rate
system
strength
recommend
assess
qualiti
evid
establish
infecti
diseas
societi
america
tabl
employ
guidelin
regard
two
way
present
state
art
outlin
research
agenda
come
decad
one
approach
guidelin
certain
gener
principl
merit
particular
attent
prevent
particular
intervent
must
clearli
defin
concern
prevent
clinic
infecti
diseas
syndrom
also
interest
prevent
indirect
consequ
infect
exampl
varieti
regimen
brought
forth
effort
prevent
direct
manifest
cytomegaloviru
cmv
infect
signific
success
perhap
even
interest
three
separ
report
suggest
antivir
prophylaxi
may
valu
decreas
incid
acut
chronic
allograft
injuri
risk
infect
solid
organ
transplant
patient
larg
determin
interact
three
factor
technicalanatom
mishap
involv
transplant
procedur
periop
aspect
care
manag
vascular
access
drain
endotrach
tube
environment
exposur
tabl
patient
net
state
immunosuppress
tabl
case
technicalanatom
mishap
best
way
prevent
infect
correct
anatom
abnorm
coverag
appropri
antimicrobi
therapi
antimicrobi
therapi
extend
incub
period
price
induc
resist
one
consid
therapi
transplant
patient
concept
therapeut
prescript
use
two
major
compon
immunosuppress
compon
prevent
treat
reject
antimicrobi
compon
make
safe
thu
natur
antimicrobi
program
administ
must
close
link
natur
intens
immunosuppress
program
requir
one
size
fit
three
mode
antimicrobi
agent
administ
transplant
recipi
therapeut
mode
antimicrobi
agent
administ
treatment
establish
clinic
infect
primari
focu
guidelin
prophylact
mode
antimicrobi
agent
administ
entir
popul
event
order
prevent
occurr
infect
import
enough
justifi
intervent
preemptiv
mode
antimicrobi
agent
administ
subpopul
note
particular
risk
clinic
import
infect
basi
clinic
epidemiolog
laboratori
marker
guidelin
focu
prevent
strategi
prophylact
preemptiv
also
diagnosi
manag
establish
period
stereotyp
tempor
pattern
timet
although
clinic
syndrom
pneumonia
occur
time
point
etiolog
differ
differ
time
point
figur
delin
timet
organ
transplant
absenc
antimicrobi
intervent
prevent
antimicrobi
therapi
fail
protect
common
clinic
effect
extend
incub
period
exampl
case
cmv
infect
absenc
prophylaxi
cmv
induc
clinic
diseas
common
month
prophylaxi
use
fail
common
diseas
occur
month
depend
natur
prophylaxi
immunosuppress
regimen
consid
timet
infect
three
time
period
recogn
differ
form
infect
first
month
first
month
three
major
caus
infect
infect
present
recipi
pretranspl
impact
increas
result
surgeri
anesthesia
immunosuppress
therapi
b
infect
convey
contamin
allograft
c
bacteri
candid
infect
wound
lung
drainag
cathet
vascular
access
devic
seen
nonimmunosuppress
patient
undergo
compar
surgeri
although
impact
tend
greater
transplant
patient
infect
occur
first
month
fall
last
categori
number
one
factor
determin
incid
infect
technic
skill
surgeri
periop
care
one
six
month
posttranspl
time
period
two
major
class
infect
time
period
immunomodul
virus
cytomegaloviru
viru
human
hepat
virus
b
c
exert
direct
effect
b
combin
sustain
immunosuppress
immunomodul
viral
infect
creat
net
state
immunosuppress
great
enough
opportunist
infect
listeria
monocytogen
aspergillu
fumigatu
pneumocysti
jiroveci
occur
without
especi
intens
environment
six
month
posttranspl
individu
divid
three
categori
patient
good
result
transplant
mainten
immunosuppress
good
allograft
function
greatest
risk
commun
acquir
respiratori
virus
eg
influenza
parainfluenza
respiratori
syncyti
viru
b
patient
chronic
hepat
infect
develop
progress
liver
failur
andor
hepatocellular
carcinoma
unless
effect
antivir
therapi
deploy
c
patient
poor
outcom
transplant
excess
acut
chronic
immunosuppress
poor
allograft
function
often
chronic
viral
infect
group
expert
term
chronic
n
er
well
highest
risk
opportunist
infect
organ
pneumocysti
jiroveci
listeria
monocytogen
cryptococcu
neoforman
nocardia
asteroid
timet
use
three
way
differenti
diagnosi
patient
possibl
infecti
diseas
syndrom
infect
control
devic
except
timet
usual
due
unusu
environment
hazard
often
within
hospit
import
context
guidelin
timet
basi
design
focus
cost
effect
prevent
antimicrobi
strategi
